Topic Hub
4 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 4 of 4 clinical reviews.
A deep dive into the FREEDOM trial's primary and secondary endpoint data for denosumab in postmenopausal osteoporosis, including effect sizes, confidence intervals, subgroup analyses, and the time-course pattern of fracture reduction.
Read clinical reviewA deep-dive into the FREEDOM trial (2009) that proved denosumab reduces vertebral fractures by 68% in postmenopausal women with osteoporosis, establishing it as a first-line therapy.
Read clinical reviewA detailed methodology breakdown of the FREEDOM trial (denosumab vs placebo for postmenopausal osteoporosis), covering randomization, blinding, endpoint definitions, statistical design, and how each choice shapes clinical interpretation.
Read clinical reviewHow the FREEDOM trial reshaped osteoporosis treatment guidelines, shifted prescribing patterns for denosumab, and what clinicians should consider for patients outside the original study population.
Read clinical review